Skip to Main Content

Paper Details

Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection.
Microbiome
33
2021
Infectious bacterial diseases, Staphylococcus aureus, bacterial infections, bacteriophages, genomes, patient, patients, staphylococcal device infection
Author NameAffiliation
Daniel McDonaldUniversity of California San Diego
Alan K JarmuschSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Alan K JarmuschSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Cameron MartinoUniversity of California San Diego
Cameron MartinoUniversity of San Diego
Cameron MartinoCenter for Microbiome Innovation, University of California San Diego
Gregory HumphreyUniversity of California San Diego
Gail AckermannUniversity of California San Diego
Pieter C DorresteinUniversity of California San Diego
Pieter C DorresteinCenter for Microbiome Innovation, University of California San Diego
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Rob KnightUniversity of California San Diego
Rob KnightCenter for Microbiome Innovation, University of California San Diego
Rob KnightUniversity of California San Diego
Rob KnightUniversity of California San Diego
  • 1 - 16

Datasets

Release 1.2